BlackRock, Inc. Increases Stake in Maravai LifeSciences Holdings, Inc.

BlackRock, Inc. has filed a Schedule 13G/A amendment, disclosing an increased ownership of 5.9% in Maravai LifeSciences Holdings, Inc. The filing indicates that BlackRock now holds 8,580,553 shares, a significant increase from previous holdings. The shares are held in the ordinary course of business and not for the purpose of influencing control of the issuer. The filing also includes certifications that the securities were not acquired to change or influence the control of Maravai LifeSciences. The amendment was signed by Spencer Fleming, Managing Director at BlackRock, Inc.